Page last updated: 2024-11-01

omeprazole and Schistosomiasis mansoni

omeprazole has been researched along with Schistosomiasis mansoni in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.

Research Excerpts

ExcerptRelevanceReference
"Omeprazole is a proton pump inhibitor which is reported to have antiparasitic properties."1.51Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice. ( Abdel Ghaffar, AE; Alshenawy, HA; Elgendy, DI; Ellakany, AR, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ellakany, AR1
Elgendy, DI1
Alshenawy, HA1
Abdel Ghaffar, AE1

Other Studies

1 other study available for omeprazole and Schistosomiasis mansoni

ArticleYear
Assessment of the potential therapeutic effects of omeprazole in Schistosoma mansoni infected mice.
    Parasitology research, 2019, Volume: 118, Issue:12

    Topics: Animals; Drug Therapy, Combination; Granuloma; Liver Cirrhosis; Male; Mice; Omeprazole; Parasite Egg

2019